Modified Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin or S-1, Irinotecan, and Oxaliplatin Versus Nab-Paclitaxel + Gemcitabine in Metastatic or Recurrent Pancreatic Cancer (GENERATE, JCOG1611): A Randomized, Open-Label, Phase II/III Trial.

Journal:

Journal of Clinical Oncology

Published:

2025-07-29

DOI:

10.1200/jco.24.00936

Affiliations:

16

Authors:

20

Go to article

Institutions	Authors	Share
National Cancer Center Hospital, Japan	4.000000	0.20
Kanagawa Cancer Center, Japan	3.000000	0.15
Cancer Institute Hospital, JFCR, Japan	2.000000	0.10
National Cancer Center Hospital East, Japan	1.000000	0.05
Kyoto University, Japan	1.000000	0.05
Osaka International Cancer Institute, Japan	1.000000	0.05
Kanazawa University (KU), Japan	1.000000	0.05
Hyogo Cancer Center, Japan	1.000000	0.05
Yokohama City University Medical Center, YCU, Japan	1.000000	0.05
Aichi Cancer Center Hospital, Japan	1.000000	0.05
Tochigi Cancer Center Research Institute, Japan	1.000000	0.05
University of Toyama, Japan	1.000000	0.05
Shizuoka Cancer Center, Japan	1.000000	0.05
Kyushu Cancer Center, Japan	1.000000	0.05

Interested in Oncology and Carcinogenesis?